Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing
Aripiprazole Open-Label, Safety and Tolerability Study
Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325